C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2030³â)
C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
»óǰÄÚµå : 1559993
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,800 £Ü 8,392,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,700 £Ü 9,694,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,850 £Ü 12,805,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»çÀÇ µ¿Çâ°ú ¿¹Ãø

¼¼°èÀÇ C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀåÀº 2024-2030³â CAGRÀÌ 3.1%·Î, 2030³â±îÁö ÃßÁ¤ 47¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á±â±â µµÀÔ È®´ë, ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÔ´Ï´Ù. ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿°, ½ÉÇ÷°ü Áúȯ, ¿°Áõ¼ºÀåÁúȯ ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖ´Â ¼¼°è C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀÇ ¹Ì·¡´Â À¯¸ÁÇÕ´Ï´Ù.

C-¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ

C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀå¿¡´Â ±â¼ú ¹ßÀü°ú ÀÇ·á ¼ö¿äÀÇ º¯È­¸¦ ¹Ý¿µÇÏ´Â ¸î °¡Áö ÁÖ¿ä µ¿ÇâÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â È¿À²¼º, Á¤È®¼º, Á¢±Ù¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á CRP °Ë»çÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ Ãß¼¼´Â °Ë»çÀÇ ¹Î°¨µµ, ÆíÀǼº, µðÁöÅÐ Çコ Åø°úÀÇ ÅëÇÕÀ» °­È­ÇÔÀ¸·Î½á CRP °Ë»ç ½ÃÀåÀ» ÀçÆíÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­¿Í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ °­Á¶´Â Á¢±Ù¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÄÑ È¯ÀÚ Ä¡·á¿Í Áø´Ü Á¤È®µµÀÇ ¹ßÀüÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

C-¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀåÀÇ ÃÖ±Ù µ¿ÇâÀº ±â¼ú ¹ßÀü°ú Á¤¹ÐÁø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ´Ù¾çÇÑ Áö¿ª¿¡¼­ CRP °Ë»çÀÇ ±â´É°ú Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ °³¹ßÀº Á¤È®¼º, È¿À²¼º, Á¢±Ù¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á CRP °Ë»ç ½ÃÀåÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. °Ë»ç ±â¼ú, ÀÚµ¿È­ ¹× ºñ¿ë È¿À²¼ºÀÇ Çõ½ÅÀº ȯÀÚ Ä¡·á¸¦ °³¼±Çϰí CRP °Ë»çÀÇ ¹üÀ§¸¦ Àü ¼¼°è¿¡¼­ È®ÀåÇϰí ÀÖ½À´Ï´Ù.

C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀå¿¡¼­ÀÇ Àü·«Àû ¼ºÀå ±âȸ

C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀåÀº ´Ù¾çÇÑ ¿ëµµ¿¡¼­ ¿©·¯ °¡Áö ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ´Â ±â¼ú ¹ßÀü°ú ÀÇ·á ¼ö¿ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀå ±âȸ´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ CRP °Ë»çÀÇ ¿ëµµ°¡ È®´ëµÇ°í ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù. ±â¼ú ¹ßÀü°ú ¼¼°è ¼ö¿ä Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇÏ¿© Áø´Ü ´É·Â Çâ»ó°ú ȯÀÚ Ä¡·á °³¼±À¸·Î À̾îÁú °ÍÀÔ´Ï´Ù.

C-¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦

C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀåÀº ´Ù¾çÇÑ ±â¼úÀû, °æÁ¦Àû, ±ÔÁ¦Àû ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦´Â Áø´Ü ºÐ¾ß ½ÃÀå ¼ºÀå, Çõ½Å ¹× Á¢±Ù¼º¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ´ÙÀ½°ú °°½À´Ï´Ù. :

1. ±â¼ú ¹ßÀü: °í°¨µµ ºÐ¼®¹ý ¹× ÇöÀåÁø´Ü±â±â¿Í °°Àº CRP °Ë»ç ±â¼úÀÇ Çõ½ÅÀº Áø´ÜÀÇ Á¤È®¼º°ú ÆíÀǼºÀ» ³ô¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº º¸´Ù Á¤È®ÇÏ°í ½Å¼ÓÇÑ ¿°Áõ °ËÃâ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù.

2. ÀÇ·á ¼ö¿ä Áõ°¡: Àü ¼¼°è ÀÇ·á ºÐ¾ß°¡ È®´ëµÊ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ´Â CRP °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÇ·á ÀÎÇÁ¶ó°¡ È®´ëµÇ¸é¼­ °í±Þ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå È®´ë¿Í ¹ßÀüÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

3. µðÁöÅÐ Çコ¿ÍÀÇ ÅëÇÕ: CRP °Ë»ç¿Í µðÁöÅÐ Çコ Ç÷§ÆûÀÇ ÅëÇÕÀº µ¥ÀÌÅÍ °ü¸®¿Í ȯÀÚ Ä¡·á¸¦ Çâ»ó½Ãŵ´Ï´Ù. Çâ»óµÈ ¿¬°á¼º°ú ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀº ´õ ³ªÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

4. ±ÔÁ¦ Áö¿ø: Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â ÷´Ü CRP °Ë»ç ±â¼úÀÇ Çõ½Å°ú äÅÃÀ» ÃËÁøÇÕ´Ï´Ù. ¸íÈ®ÇÑ °¡À̵å¶óÀΰú ½ÂÀÎÀº ½ÃÀå ÁøÀÔÀ» °£¼ÒÈ­ÇÏ°í °íǰÁú Áø´Ü ¼Ö·ç¼ÇÀÇ Á¦°øÀ» º¸ÀåÇÕ´Ï´Ù.

5. ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç: Àú·ÅÇÑ CRP °Ë»ç ¿É¼ÇÀ» °³¹ßÇÏ¸é Æ¯È÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­ ½ÃÀå Á¢±Ù¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀº ÀÇ·á Á¢±Ù¼ºÀ» È®´ëÇϰí, Áø´Ü ´É·ÂÀ» Çâ»ó½Ã۸ç, ÀÇ·á Á¢±Ù¼º °ÝÂ÷¸¦ ÇØ¼ÒÇÒ ¼ö ÀÖ½À´Ï´Ù.

CRP °Ë»ç ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦´Â ´ÙÀ½°ú °°½À´Ï´Ù. :

1. ÷´Ü ±â¼úÀÇ ³ôÀº ºñ¿ë: °í±Þ CRP °Ë»ç ±â¼úÀÇ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ Á¢±Ù¼ºÀÌ Á¦ÇÑµÇ¾î ½ÃÀå ħÅõ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. °í°¡ÀÇ Àåºñ¿Í ºÐ¼®¹ýÀº Àú¼Òµæ Áö¿ª°ú ÀÇ·á ȯ°æ¿¡¼­ÀÇ Ã¤ÅÃÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

2. º¹ÀâÇÑ ±ÔÁ¦ ȯ°æ: Áö¿ªº°·Î »óÀÌÇÑ º¹ÀâÇÑ ±ÔÁ¦ ±âÁØÀ» ±Øº¹ÇÏ´Â °ÍÀÌ °úÁ¦ÀÔ´Ï´Ù. Á¦Á¶¾÷ü´Â ´Ù¾çÇÑ ±ÔÁ¦¸¦ ÁؼöÇØ¾ß Çϸç, ÀÌ´Â ¿î¿µ ºñ¿ëÀ» Áõ°¡½ÃŰ°í ½ÃÀå ÁøÀÔ ¹× ½ÃÀå È®´ë ³ë·ÂÀ» º¹ÀâÇÏ°Ô ¸¸µì´Ï´Ù.

3. °æÁ¦Àû Á¦¾à: °æ±â º¯µ¿Àº CRP °Ë»ç ±â¼úÀÇ °¡°Ý ¹× °¡¿ë¼º¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÇ ¿¹»ê Á¦¾àÀº ±¸¸Å °áÁ¤¿¡ ¿µÇâÀ» ¹ÌÄ¡°í °æÁ¦ÀûÀ¸·Î ¾î·Á¿î Áö¿ª ½ÃÀå ¼ºÀåÀ» µÐÈ­½Ãų ¼ö ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀü, ÀÇ·á ¼ö¿ä Áõ°¡, µðÁöÅÐ Çコ¿ÍÀÇ ÅëÇÕ µî ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀÌ CRP °Ë»ç ½ÃÀåÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ±â¼ú ºñ¿ë, º¹ÀâÇÑ ±ÔÁ¦ ȯ°æ, °æÁ¦Àû Á¦¾à°ú °°Àº °úÁ¦´Â ½ÃÀåÀÇ ÀáÀç·ÂÀ» ÃæºÐÈ÷ ¹ßÈÖÇÏ°í °í±Þ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Á¢±ÙÀ» º¸ÀåÇϱâ À§ÇØ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ÀÔ´Ï´Ù.

ºÎ¹®º° C-¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç

ÀÌ º¸°í¼­¿¡´Â ¼¼°è C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç¿¡ ´ëÇÑ ºÐ¼® À¯Çüº°, ¿ëµµº°, Áö¿ªº° ¿¹ÃøÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀå ±¹°¡º° Àü¸Á

C ¹ÝÀÀ¼º ´Ü¹éÁú(CRP) °Ë»ç ½ÃÀåÀº ±â¼ú ¹ßÀü, ½Å¼ÓÇÑ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ´Ù¾çÇÑ Áö¿ªÀû µ¿Çâ¿¡ µû¶ó ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿òÁ÷ÀÓÀº ´Ù¾çÇÑ ÀÇ·á ½Ã½ºÅÛ¿¡¼­ º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ ¿°Áõ ¸¶Ä¿ °Ë»ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1. ½ÃÀå ±Ô¸ð :

A1. ¼¼°è C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀº 2030³â±îÁö ¾à 47¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q2. ½ÃÀåÀÇ ¼ºÀå ¿¹ÃøÀº :

A2. ¼¼°è C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀº 2024-2030³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 3.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q3. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº :

A3.ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ³ëÀÎ Àα¸ Áõ°¡, POC(Point-Of-Care) ±â±â µµÀÔ È®´ë, ÀÇ·á ¼­ºñ½º ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº :

A4.C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀåÀÇ ¹Ì·¡´Â ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿°, ½ÉÇ÷°ü Áúȯ, ¿°Áõ¼ºÀåÁúȯ ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖÀ¸¸ç, À¯¸ÁÇÕ´Ï´Ù.

Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº :

A5.C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù. :

Q6. ÇâÈÄ ÃÖ´ë°¡ µÇ´Â ½ÃÀå ºÎ¹®Àº :

A6.LucintelÀº ¸é¿ªºñħÅõ¹ýÀº ±¤¹üÀ§ÇÑ CRP °ªÀ» ¹Î°¨ÇÏ°Ô ÃøÁ¤ÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¿¹Ãø ±â°£ Áß °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

Q7. ½ÃÀå¿¡¼­ ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº :

A7. ºÏ¹Ì´Â ¿°Áõ¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, °Ç°­¿¡ ÇØ·Î¿î »ýȰ½À°üÀÇ º¯È­, ³ôÀº ÀÇ·áºñ ÁöÃâ·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

Q8. ¸®Æ÷Æ®ÀÇ Ä¿½ºÅ͸¶ÀÌÁî´Â °¡´ÉÇѰ¡? :

A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ Ä¿½ºÅ͸¶ÀÌÁ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼¼°èÀÇ C ¹ÝÀÀ¼º ´Ü¹éÁú °Ë»ç ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå 2018-2030³â ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦4Àå 2018-2030³â Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·« ºÐ¼®

Á¦7Àå ÁÖ¿ä ±â¾÷ÀÇ ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

C Reactive Protein Testing Trends and Forecast

The future of the global C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets. The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

Emerging Trends in the C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market is experiencing several key trends that reflect advancements in technology and shifts in healthcare needs. These trends are shaping the future of CRP testing by enhancing efficiency, accuracy, and accessibility.

These trends are reshaping the CRP testing market by enhancing test sensitivity, convenience, and integration with digital health tools. The emphasis on automation and cost-effective solutions is improving accessibility and efficiency, driving advancements in patient care and diagnostic accuracy.

Recent Developments in the C Reactive Protein Testing Market

Recent developments in the C-Reactive Protein (CRP) testing market reflect advancements in technology and increasing demand for precise diagnostic tools. These developments are enhancing the capabilities and accessibility of CRP testing across various regions.

These developments are advancing the CRP testing market by improving accuracy, efficiency, and accessibility. Innovations in testing technologies, automation, and cost-effectiveness are enhancing patient care and expanding the reach of CRP testing globally.

Strategic Growth Opportunities for C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market presents several growth opportunities across various applications. These opportunities are driven by advancements in technology and increasing healthcare demands.

These growth opportunities highlight the expanding applications of CRP testing across various healthcare settings. Advancements in technology and increasing global demand are driving the market, enhancing diagnostic capabilities and improving patient care.

C Reactive Protein Testing Market Driver and Challenges

The C-Reactive Protein (CRP) testing market is influenced by various technological, economic, and regulatory factors. These drivers and challenges impact market growth, innovation, and accessibility in the diagnostic sector.

The factors responsible for driving the c reactive protein testing market include:

1. Technological Advancements: Innovations in CRP testing technologies, such as high-sensitivity assays and point-of-care devices, drive market growth by enhancing diagnostic accuracy and convenience. These advancements meet the increasing demand for more precise and rapid inflammation detection.

2. Increasing Healthcare Demand: The growing global healthcare sector increases the need for reliable CRP testing. Rising awareness and expanding healthcare infrastructure drive demand for advanced diagnostic tools, supporting market expansion and development.

3. Integration with Digital Health: The integration of CRP testing with digital health platforms improves data management and patient care. Enhanced connectivity and real-time monitoring capabilities drive market growth by facilitating better clinical decision-making.

4. Regulatory Support: Supportive regulatory frameworks promote innovation and adoption of advanced CRP testing technologies. Clear guidelines and approvals streamline market entry and ensure the availability of high-quality diagnostic solutions.

5. Cost-Effective Solutions: The development of affordable CRP testing options enhances market accessibility, particularly in low-resource settings. Cost-effective solutions expand reach and improve diagnostic capabilities, addressing disparities in healthcare access.

Challenges in the c reactive protein testing market are:

1. High Cost of Advanced Technologies: The high cost of advanced CRP testing technologies can limit accessibility and impact market penetration. Expensive equipment and assays may restrict adoption in lower-income regions and healthcare settings.

2. Complex Regulatory Environment: Navigating complex and varying regulatory standards across regions poses challenges. Manufacturers must comply with diverse regulations, increasing operational costs and complicating market entry and expansion efforts.

3. Economic Constraints: Economic fluctuations can affect the affordability and availability of CRP testing technologies. Budget constraints in healthcare systems may impact purchasing decisions and slow market growth in economically challenged regions.

The drivers of technological advancements, increasing healthcare demand, and integration with digital health are propelling the CRP testing market forward. However, challenges such as high technology costs, complex regulatory environments, and economic constraints must be addressed to fully realize market potential and ensure widespread access to advanced diagnostic solutions.

List of C Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies C reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C reactive protein testing companies profiled in this report include-

C Reactive Protein Testing by Segment

The study includes a forecast for the global C reactive protein testing by assay type, application, and region.

C Reactive Protein Testing Market by Assay Type [Analysis by Value from 2018 to 2030]:

C Reactive Protein Testing Market by Application [Analysis by Value from 2018 to 2030]:

C Reactive Protein Testing Market by Region [Analysis by Value from 2018 to 2030]:

Country Wise Outlook for the C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market is evolving with advancements in technology, increasing demand for rapid diagnostics, and varying regional trends. These developments are driven by the need for more accurate and efficient inflammatory marker testing across different healthcare systems.

Features of the Global C Reactive Protein Testing Market

Market Size Estimates: C reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C reactive protein testing market size by assay type, application, and region in terms of value ($B).

Regional Analysis: C reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay types, applications, and regions for the C reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the C reactive protein testing market size?

Answer: The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030.

Q2. What is the growth forecast for C reactive protein testing market?

Answer: The global C reactive protein testing market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C reactive protein testing market?

Answer: The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

Q4. What are the major segments for C reactive protein testing market?

Answer: The future of the C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets.

Q5. Who are the key C reactive protein testing market companies?

Answer: Some of the key C reactive protein testing companies are as follows:

Q6. Which C reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Q7. In C reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global C Reactive Protein Testing Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â